Hjem › Hidradenitis suppurativa › Massachusetts
Hidradenitis suppurativa kliniske forsøg i Massachusetts
10 studier for Hidradenitis suppurativa søger deltagere på steder i Massachusetts.
Byer i Massachusetts
Officiel studietekst (engelsk)
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 3, Boston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07828860A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center - Boston- Site Number : 8400001, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07225569A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 104, Boston
RekruttererFase 1
Alder 18 og opefter · Kvinder · Opdateret 18. sep. 2026 · NCT06888193Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US030, Boston
- Investigative Site US048, Brighton
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06855498Targeting Nociceptors in Hidradenitis Suppurativa
- University of Massachusetts Chan Medical School, Worcester
RekruttererObservationsstudie
Alder 18 til 75 · Alle køn · Opdateret 10. sep. 2026 · NCT05403710Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Boston Childrens Hospital, Boston
RekruttererFase 2
Alder 12 til 17 · Alle køn · Opdateret 6. aug. 2026 · NCT07213973A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center, Boston
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 22. jul. 2026 · NCT07384975The Safety and Efficacy of Roflumilast Foam in HS
- Beth Israel Deaconess Medical Center, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. jul. 2026 · NCT07263230A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Tufts University, Boston
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
RekruttererObservationsstudie
Alder 18 til 71 · Alle køn · Opdateret 16. apr. 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center, Boston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 6. mar. 2026 · NCT07244263Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.